Financial Summary (All financials)
In millions, except per share items | Mar-31-15 | Mar-31-14 | Mar-31-13 | Mar-31-12 | Mar-31-11 | Mar-31-10 |
Revenues | 163,329 | 111,878 | 132,903 | 141,048 | 99,634 | 53,225 |
Revenue growth | 46.0% | -15.8% | -5.8% | 41.6% | 87.2% | |
Cost of goods sold | 72,903 | 62,545 | 63,983 | 72,300 | 51,164 | 27,297 |
Gross profit | 90,426 | 49,333 | 68,920 | 68,748 | 48,470 | 25,928 |
Gross margin | 55.4% | 44.1% | 51.9% | 48.7% | 48.6% | 48.7% |
Selling, general and administrative | 45,720 | 39,964 | 35,778 | 37,608 | 21,162 | 19,671 |
Research and development | 29,876 | 32,670 | 33,062 | 30,303 | 21,197 | 17,896 |
EBITA | 15,468 | -34,185 | 2,330 | 3,349 | 6,343 | -11,426 |
EBITA margin | 9.5% | -30.6% | 1.8% | 2.4% | 6.4% | -21.5% |
Amortization of intangibles | 849 | 2,162 | 2,285 | 2,512 | 232 | 213 |
EBIT | 14,619 | -36,347 | 45 | 837 | 6,111 | -11,639 |
EBIT margin | 9.0% | -32.5% | 0.0% | 0.6% | 6.1% | -21.9% |
Pre-tax income | 14,619 | -35,086 | 941 | 1,420 | 6,276 | -11,496 |
Income taxes | 5,911 | 61 | 2,493 | -1,240 | 2,352 | 1,457 |
Tax rate | 40.4% | | 264.9% | | 37.5% | |
Net income | 12,948 | -35,540 | -3,821 | -2,195 | 3,163 | -11,454 |
Net margin | 7.9% | -31.8% | -2.9% | -1.6% | 3.2% | -21.5% |
|
Diluted EPS | $67.25 | ($204.10) | ($22.03) | ($12.67) | $18.02 | ($64.09) |
Shares outstanding (diluted) | 193 | 174 | 173 | 173 | 175 | 179 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|